Cargando…

Is Ep-CAM Expression a Diagnostic and Prognostic Biomarker for Colorectal Cancer? A Systematic Meta-Analysis

BACKGROUND: Cancer stem cell (CSC) epithelial cell adhesion molecule (Ep-CAM) is frequently expressed in colorectal cancer (CRC). However, the clinical significance of Ep-CAM expression in CRC is not clear. This study evaluated whether Ep-CAM provided valuable insight as a molecular biomarker for CR...

Descripción completa

Detalles Bibliográficos
Autores principales:	Han, Susu, Zong, Shaoqi, Shi, Qi, Li, Hongjia, Liu, Shanshan, Yang, Wei, Li, Wen, Hou, Fenggang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2017
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5478257/ https://www.ncbi.nlm.nih.gov/pubmed/28558958 http://dx.doi.org/10.1016/j.ebiom.2017.05.025

Ejemplares similares

Clinicopathological, prognostic and predictive value of CD166 expression in colorectal cancer: a meta-analysis
por: Han, Susu, et al.
Publicado: (2017)

Exploring the medication duration based on the effect of traditional Chinese medicine on postoperative stage I-III colorectal patients: a retrospective cohort study
por: Shi, Qi, et al.
Publicado: (2017)

Hypoxia-induced vasculogenic mimicry formation in human colorectal cancer cells: Involvement of HIF-1a, Claudin-4, and E-cadherin and Vimentin
por: Li, Wen, et al.
Publicado: (2016)

DNMT1, DNMT3A and DNMT3B Polymorphisms Associated With Gastric Cancer Risk: A Systematic Review and Meta-analysis
por: Li, Hongjia, et al.
Publicado: (2016)

Yi Ai Fang, a traditional Chinese herbal formula, impacts the vasculogenic mimicry formation of human colorectal cancer through HIF-1α and epithelial mesenchymal transition
por: Hou, Fenggang, et al.
Publicado: (2016)

A Chinese Herbal Formula Suppresses Colorectal Cancer Migration and Vasculogenic Mimicry Through ROS/HIF-1α/MMP2 Pathway in Hypoxic Microenvironment
por: Zong, Shaoqi, et al.
Publicado: (2020)

Prevention of cisplatin-based chemotherapy-induced delayed nausea and vomiting using triple antiemetic regimens: a mixed treatment comparison
por: Shi, Qi, et al.
Publicado: (2016)

Prognostic Value of CD44 and Its Isoforms in Advanced Cancer: A Systematic Meta-Analysis With Trial Sequential Analysis
por: Han, Susu, et al.
Publicado: (2019)

Prognostic value of ALDH1 and Nestin in advanced cancer: a systematic meta-analysis with trial sequential analysis
por: Han, Susu, et al.
Publicado: (2019)

Prognostic Value of CD133 and SOX2 in Advanced Cancer
por: Han, Susu, et al.
Publicado: (2019)

MicroRNAs and angiogenesis: a new era for the management of colorectal cancer
por: Tang, Yufei, et al.
Publicado: (2021)

The detection of EpCAM(+) and EpCAM(–) circulating tumor cells
por: Wit, Sanne de, et al.
Publicado: (2015)

Diagnostic and Prognostic Values of Serum EpCAM, TGM2, and HE4 Levels in Endometrial Cancer
por: Lan, Ting, et al.
Publicado: (2020)

Expression of EpCAM(MF) and EpCAM(MT) variants in human carcinomas
por: Fong, Dominic, et al.
Publicado: (2014)

miRNA profiling of circulating EpCAM(+) extracellular vesicles: promising biomarkers of colorectal cancer
por: Ostenfeld, Marie Stampe, et al.
Publicado: (2016)

EpCAM as a Novel Biomarker for Survivals in Prostate Cancer Patients
por: Liao, Yang, et al.
Publicado: (2022)

Clinical prognostic value of combined analysis of Aldh1, Survivin, and EpCAM expression in colorectal cancer
por: Goossens-Beumer, I J, et al.
Publicado: (2014)

The prognostic value of hypoxia-inducible factor-1α in advanced cancer survivors: a meta-analysis with trial sequential analysis
por: Han, Susu, et al.
Publicado: (2019)

EpCAM expression negatively regulates E-cadherin function in colorectal carcinomas
por: Ezenkwa, Uchenna Simon, et al.
Publicado: (2023)

Expression of EpCAM in uveal melanoma
por: Odashiro, Danilo N, et al.
Publicado: (2006)

Biology and clinical relevance of EpCAM
por: Keller, Laura, et al.
Publicado: (2019)

EpCAM as Modulator of Tissue Plasticity
por: Fagotto, François
Publicado: (2020)

EpCAM(high) and EpCAM(low) circulating tumor cells in metastatic prostate and breast cancer patients
por: de Wit, Sanne, et al.
Publicado: (2018)

Loss of TINCR expression promotes proliferation, metastasis through activating EpCAM cleavage in colorectal cancer
por: Zhang, Zuo-yang, et al.
Publicado: (2016)

Prognostic value of biomarkers EpCAM and αB-crystallin associated with lymphatic metastasis in breast cancer by iTRAQ analysis
por: Zeng, Liang, et al.
Publicado: (2019)

IgG-like Bispecific Antibody CD3×EpCAM Generated by Split Intein Against Colorectal Cancer
por: Wang, Lei, et al.
Publicado: (2022)

EpCAM aptamer mediated cancer cell specific delivery of EpCAM siRNA using polymeric nanocomplex
por: Subramanian, Nithya, et al.
Publicado: (2015)

Construction of interference vector targeting Ep-CAM gene and its effects on colorectal cancer cell proliferation
por: Qi, Yanmei, et al.
Publicado: (2015)

Functions of EpCAM in physiological processes and diseases (Review)
por: Huang, Li, et al.
Publicado: (2018)

Current View on EpCAM Structural Biology
por: Gaber, Aljaž, et al.
Publicado: (2020)

Evolution of Thyroglobulin Loop Kinetics in EpCAM
por: Chen, Serena H., et al.
Publicado: (2021)

Detection of soluble EpCAM (sEpCAM) in malignant ascites predicts poor overall survival in patients treated with catumaxomab
por: Seeber, Andreas, et al.
Publicado: (2015)

EpCAM expression in squamous cell carcinoma of the uterine cervix detected by monoclonal antibody to the membrane-proximal part of EpCAM
por: Chantima, Warangkana, et al.
Publicado: (2017)

Correction to: EpCAM aptamer mediated cancer cell specific delivery of EpCAM siRNA using polymeric nanocomplex
por: Subramanian, Nithya, et al.
Publicado: (2020)

Urinary EpCAM in urothelial bladder cancer patients: characterisation and evaluation of biomarker potential
por: Bryan, R T, et al.
Publicado: (2014)

Construction, Expression, and Characterization of a Recombinant Immunotoxin Targeting EpCAM
por: Lv, Minghua, et al.
Publicado: (2015)

Antitumor activities of a defucosylated anti-EpCAM monoclonal antibody in colorectal carcinoma xenograft models
por: Li, Guanjie, et al.
Publicado: (2023)

Peritumoral EpCAM Is an Independent Prognostic Marker after Curative Resection of HBV-Related Hepatocellular Carcinoma
por: Dai, Xiao-Meng, et al.
Publicado: (2017)

Combination Therapy with EpCAM-CAR-NK-92 Cells and Regorafenib against Human Colorectal Cancer Models
por: Zhang, Qing, et al.
Publicado: (2018)

EpCAM Knockdown Alters MicroRNA Expression in Retinoblastoma- Functional Implication of EpCAM Regulated MiRNA in Tumor Progression
por: Beta, Madhu, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_5p27806tesrg0uh9cpefdsoalc